Hi-Great Group Holding Company

Equities

HIGR

US4283711087

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:40:02 2022-10-18 pm EDT			5-day change	1st Jan Change
0.0178 ^USD	-98.22%		-.--%	-.--%

2023	Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2022

April 17, 2023 at 06:19 am EDT

Hi-Great Group Holding Company reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.207854 million compared to USD 0.264194 million a year ago. Net income was USD 0.0033 million compared to USD 0.002579 million a year ago.

Latest news about Hi-Great Group Holding Company

Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Hi-Great Group Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-19	CI
Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	23-04-16	CI
Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-06	CI
Hi-Great Group Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-08-01	CI
Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-07-12	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	22-07-11	CI
Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22-05-09	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2021	22-05-02	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	22-02-23	CI

Chart Hi-Great Group Holding Company

Duration

Period

More charts

Company Profile

Hi-Great Group Holding Company holds a license agreement for New Business Plan with the KRAS gene, which is among the most frequently mutated genes across all cancers, including pancreatic, lung, and colorectal. The Company is engaged in marketing, selling, and distributing SellaCare, Inc's organic longevity health supplement. The Company is in license agreement with SellaCare, Inc. in the areas of longevity and additional health benefits and it also expands into the cosmetic sector as an overall sustainable revenue platform.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HI-GREAT GROUP HOLDING COMPANY	-.--%	1.78M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+48.32%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research